Mind + Muscle

technical minds + legal muscle


dig deep

The Patent Landscape of siRNA Nanoparticle Delivery

  • 03.06.14
  • Robert W. Esmond, Ph.D. and Alex Kwan-Ho Chung
  • Nanotechnology Law & Business

Robert Esmond and Alex Chung authored an article discussing small interfering RNAs (siRNAs) and potential issues surrounding its commercialization. Despite a number of patent filings claiming nanoparticle delivery of siRNA, the authors expect that companies will be able to develop proprietary siRNA drugs with few limitations. 

To read the full article, download the attached PDF.

Related People

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.